Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04043897
PHASE2

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

Sponsor: Eugene F Yen, MD

View on ClinicalTrials.gov

Summary

This is an open label study looking at rifaximin therapy for the treatment of microscopic (collagenous or lymphocytic) colitis.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2018-06-29

Completion Date

2021-12

Last Updated

2021-04-15

Healthy Volunteers

No

Interventions

DRUG

Rifaximin 550mg

Rifaximin 550mg

Locations (1)

NorthShore University HealthSystem

Evanston, Illinois, United States